Record Details

Recent US-China tariff war: Opportunities for Indian pharmaceutical exports?

Journal of Economics Bibliography

View Archive Info
 
 
Field Value
 
Title Recent US-China tariff war: Opportunities for Indian pharmaceutical exports?
 
Creator CHAKRABORTY, Debashis; Indian Institute of Foreign Trade (IIFT), IIFT Bhawan, B-21, Qutab Institutional Area, New Delhi 110016, India. Telephone: +91 11 2696 6563; +91 11 2696 5124;Mobile: +91 9818447900; Facsimile: +91-11-2685-3956 . E-mail: debchakra@gmail.com
MAHESHWARI, Sourabh;

MBA Student, Indian Institute of Foreign Trade, Kolkata Campus, 1583, Madurdaha, Chowbaga Canal Side Road, Kolkata – 700107, West Bengal, Mail: sauravm_kd19@iift.edu, Mob: 91-8879368898.


PARASHAR, Sushil;

MBA Student, Indian Institute of Foreign Trade, Kolkata Campus, 1583, Madurdaha, Chowbaga Canal Side Road, Kolkata – 700107, West Bengal, Mail: sushil_kd19@iift.edu, Mob: 91-7011531457.
 
Subject India; US; Pharmaceutical trade; Trade indices; Trade policy; Make in India.
F10; F13.
 
Description Abstract. The inception of World Trade Organization (WTO) in 1995 was expected to reduce trade barriers across member countries on one hand and facilitate growth though promotion of international trade in merchandise products and services on the other. The subsequent WTO-led reforms deepened the globalization wave. In recent times however, the world is witnessing a phase of ‘de-globalization’, with rise in trade barriers and inwardness. The recent increase in US tariffs on Chinese exports and countermeasures imposed by China are a case in point. In 2014 India has initiated the Make-in-India scheme for deepening industrialization and facilitating exports. The current paper evaluates the possible opportunities for expanding Indian pharmaceutical exports in the US market, given the increase in tariff against Chinese products with the help of select trade indices. The analysis portrays a modest opportunity for Indian pharmaceutical exports in the US market, based on their past performance. Only six products at HS 6-digit level, based on the six indicators, are found to be enjoying competitiveness in the US market. The paper concludes that facilitating R&D in pharma segment as well as expanding the coverage of mutual recognition of standards in US may be explored as possible steps for enhancing Indian exports.Keywords. India, US, Pharmaceutical trade, Trade indices, Trade policy, Make in India.JEL. F10, F13.
 
Publisher Journal of Economics Bibliography
 
Contributor —
 
Date 2018-12-30
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
 
Format application/pdf
 
Identifier http://www.kspjournals.org/index.php/JEB/article/view/1778
10.1453/jeb.v5i4.1778
 
Source Journal of Economics Bibliography; Vol 5, No 4 (2018): December; 209-222
2149-2387
 
Language eng
 
Relation http://www.kspjournals.org/index.php/JEB/article/view/1778/1786
 
Rights Copyright (c) 2019 Journal of Economics Bibliography
http://creativecommons.org/licenses/by-nc/4.0